People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Other Health Care, Other, Biotechnology, Computers, Pharmaceuticals, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mdp Hc Holdings, Llc | — | Other Health Care | Series D+ | $310.1M | $7.1B | 2015 |
| Mustang Investment Holdings L.P. | — | Other | Series D+ | $166.6M | $2.9B | 2014 |
| Angiocrine Bioscience, Inc. | — | Biotechnology | Series C | $64.2M | $12.1M | 2021 |
| Mdp Acm Holdings, Llc | — | Other Health Care | Series C | $60.0M | $1.4B | 2018 |
| CDW Corp | — | Computers | Series C | $58.7M | $2.2B | 2015 |
| Harrow Health, Inc. | — | Pharmaceuticals | Series A | $29.2M | $226.5M | 2012 |
| Aligned Exteriors Group LLC | — | Other | Series B | $23.0M | $127.4M | 2024 |
| Procurated, Inc. | — | Other Technology | Series A | $18.7M | $36.8M | 2021 |
| Pine Street Healthcare Holdings, LLC | — | Healthtech | Series A | $11.5M | $84.7M | 2023 |
| River Sea PSCP Roofing Investor LLC | — | Other | Series A | $5.7M | $22.7M | 2024 |
| Pshuh, Llc | — | Other Health Care | Seed | $4.0M | $27.7M | 2023 |
Paul Finnegan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul Finnegan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| SAMUEL MENCOFF | 3 | 3 |
| Timothy Sullivan | 2 | 16 |
| Nicholas Alexos | 2 | 6 |
| Michael Davidov | 2 | 3 |
| KARLA BULLARD | 2 | 3 |
| Jonathan Sassover | 2 | 2 |
| Jacob Meister | 2 | 2 |
| Alexander Study | 2 | 2 |
| Griffin Rotman | 2 | 2 |
| Teresa F. Sparks | 1 | 30 |
| Richard Lindstrom | 1 | 13 |
| Richard L Lindstrom | 1 | 8 |
| Marc Cohen | 1 | 6 |
| Mark L. Baum | 1 | 5 |
| Jeff Jonas | 1 | 5 |
| Patrick Eilers | 1 | 4 |
| Jeffrey Port | 1 | 4 |
| Mark Baum | 1 | 4 |
| Michael Cole | 1 | 3 |
| Andrew Boll | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.